The World Health Organization on CBD
The position of the World Health Organization on CBD , cannabidiol, one of the active ingredients contained in cannabis, has been made known in these hours . Extracts and compounds containing CBD have long been freely sold in the UK, generally as food supplements. Unlike THC, the other main active ingredient contained in cannabis, CBD has no psychotropic effects and is not addictive, while there are many therapeutic applications.
The CBD is considered a good analgesic, and is successfully used to alleviate migraines, chronic pain, arthritis and inflammation in general. It also has anti-emetic properties, against vomiting and nausea and it is also a powerful anticonvulsant and neuroleptic applied to cases of epilepsy, even in the age of the child. It has also been indicated as useful for the treatment of multiple sclerosis.
According to the committee of experts on drugs and addictions of the World Health Organization, which met in November 2018, the current evidence regarding CBD does not justify its inclusion in the substances subjected to control by the international conventions on drugs. However, the committee postponed a further evaluation in May 2018.